Three cases of non-occlusive mesenteric ischemia that developed after head and neck cancer therapy
| Autor: | Junichiro Ohori, Hiromi Nagano, Yuichi Kurono, Hirohisa Matsuzaki, Mizuo Umakoshi, Yoshinobu Fujiwara |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Abdominal pain medicine.medical_treatment Ischemia Hypopharyngeal Carcinoma Necrosis 03 medical and health sciences Fatal Outcome Postoperative Complications 0302 clinical medicine medicine Humans 030223 otorhinolaryngology Aged Aged 80 and over Chemotherapy Hypopharyngeal Neoplasms business.industry Head and neck cancer Chemoradiotherapy General Medicine medicine.disease Surgery Intestines Oropharyngeal Neoplasms Otorhinolaryngology Mesenteric ischemia Mesenteric Ischemia 030220 oncology & carcinogenesis medicine.symptom business Complication |
| Zdroj: | Auris Nasus Larynx. 48:1193-1198 |
| ISSN: | 0385-8146 |
| DOI: | 10.1016/j.anl.2020.07.003 |
| Popis: | Non-occlusive mesenteric ischemia (NOMI) causes intestinal necrosis due to irreversible ischemia of the intestinal tract despite the absence of organic obstruction in the mesenteric blood vessels. The disease has extremely poor prognosis. We report three cases of NOMI hypothesized to have developed after head and neck cancer therapy; thus, we report these cases considering the available literature. Case 1: A 74-year-old man with T2N0M0 stage Ⅱ oropharyngeal carcinoma complained of abdominal pain 5 days after chemoradiotherapy. The patient was diagnosed with NOMI, and an emergency surgery was performed. Case 2: A 69-year-old man with T2N2bM0 stage IVA hypopharyngeal carcinoma complained of abdominal pain during TPF chemotherapy. The patient was diagnosed with NOMI, and he died on the same day. Case 3: A 82-year-old man with T2N2bM0 stage IVA hypopharyngeal carcinoma complained of abdominal pain with reduced level of consciousness, 5 days after total laryngopharyngectomy. The patient was diagnosed with NOMI, and an emergency surgery was performed on the same day. We therefore suggest that ENT physicians must be aware of NOMI as a complication that can develop after head and neck cancer therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect